A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the ...

Findings could redefine the treatment for millions of children worldwide with asthma, after this comparison of two types of ...

Inhaler Reduces Asthma Attacks by 45% The results show that using a single 2-in-1 anti-inflammatory reliever inhaler – which ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated.

Credit: AstraZeneca. Airsupra combines albuterol, a short-acting beta2-agonist, and budesonide, an inhaled corticosteroid. Airsupra ® (albuterol/budesonide) is now available for the as-needed ...

Discover a study showing budesonide–formoterol cuts childhood asthma attacks by 45%, offering a safer alternative to ...

International asthma guidelines increasingly support the use of inhaled corticosteroid plus fast-acting β-agonist ...

Please provide your email address to receive an email when new articles are posted on . The study treatment, PT027, is a potential first-in class inhaled, fixed-dose combination rescue medication ...

In a recent study published in the Annals of Internal Medicine, researchers performed a randomized, placebo-controlled trial (RCT) among adults with confirmed severe acute respiratory syndrome ...

December 29, 2011 — A budesonide/formoterol pressurized metered dose inhaler (pMDI) reduced chronic obstructive pulmonary disease (COPD) exacerbations more effectively than a formoterol dry powder ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research ...

A new study found that a 2-in-1 anti-inflammatory inhaler reduced asthma attacks in children by 45% compared to the ...